Mitsubishi UFJ Asset Management (UK)’s ANI Pharmaceuticals ANIP Stock Holding History

Mitsubishi UFJ Asset Management (UK)’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.49M	Hold	18,000	–	–	0.69%	49
2026 Q1	$1.38M	Buy	18,000 +5,000	+38%	+$390K	0.72%	49
2025 Q4	$1.03M	Buy	13,000 +5,000	+63%	+$433K	0.5%	58
2025 Q3	$733K	Buy	8,000 +3,000	+60%	+$245K	0.35%	72
2025 Q2	$326K	Hold	5,000	–	–	0.17%	95
2025 Q1	$335K	Buy	+5,000	New	+$299K	0.18%	93
2024 Q3	–	Sell	-4,000	Closed	-$255K	–	115
2024 Q2	$255K	Hold	4,000	–	–	0.13%	95
2024 Q1	$277K	Hold	4,000	–	–	0.14%	97
2023 Q4	$221K	Sell	4,000 -6,000	-60%	-$330K	0.12%	82
2023 Q3	$581K	Sell	10,000 -5,000	-33%	-$289K	0.41%	79
2023 Q2	$807K	Hold	15,000	–	–	0.52%	62
2023 Q1	$596K	Sell	15,000 -8,000	-35%	-$337K	0.39%	79
2022 Q4	$925K	Hold	23,000	–	–	0.65%	54
2022 Q3	$739K	Hold	23,000	–	–	0.57%	59
2022 Q2	$682K	Hold	23,000	–	–	0.39%	68
2022 Q1	$647K	Buy	23,000 +7,000	+44%	+$261K	0.29%	84
2021 Q4	$737K	Hold	16,000	–	–	0.31%	77
2021 Q3	$525K	Buy	+16,000	New	+$497K	0.22%	83
2019 Q4	–	Sell	-13,000	Closed	-$947K	–	80
2019 Q3	$947K	Hold	13,000	–	–	0.44%	59
2019 Q2	$1.07M	Buy	+13,000	New	+$925K	0.46%	60

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mitsubishi UFJ Asset Management (UK)'s ANIP Position: Q2 2026 in Review

Mitsubishi UFJ Asset Management (UK) held its ANI Pharmaceuticals (ANIP) position steady in Q2 2026 at 18,000 shares worth $1.49M. The position accounts for 0.69% of the portfolio, ranked #49.

Mitsubishi UFJ Asset Management (UK) first reported a position in ANIP in Q2 2019 and has held it in 20 quarters since. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

Mitsubishi UFJ Asset Management (UK) held 18,000 shares of ANI Pharmaceuticals worth $1.49M as of Q2 2026.
Mitsubishi UFJ Asset Management (UK) left its ANI Pharmaceuticals share count unchanged in Q2 2026.
ANI Pharmaceuticals made up 0.69% of Mitsubishi UFJ Asset Management (UK)'s portfolio in Q2 2026, its #49 holding.
Mitsubishi UFJ Asset Management (UK) first reported a position in ANI Pharmaceuticals in Q2 2019 and has held it in 20 quarters since.
307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Mitsubishi UFJ Asset Management (UK)'s 13F filing for Q2 2026, filed 28 Jul 2026.